APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy

Journal: Nature Communications

Published: 2020-02-07

DOI: 10.1038/s41467-020-14568-7

Affiliations: 12

Authors: 20

Go to article
Institutions Share
Mayo Clinic Department of Molecular Medicine, United States of America (USA) 0.40
Department of Biochemistry, Molecular Biology, and Biophysics (BMBB), UMN, United States of America (USA) 0.10
Faculty of Medicine and Health, University of Leeds, United Kingdom (UK) 0.10
ICR Division of Radiotherapy and Imaging, United Kingdom (UK) 0.10
Mayo Clinic Graduate School of Biomedical Sciences, United States of America (USA) 0.05
Mayo Clinic Department of Immunology, United States of America (USA) 0.05
Phoenix Children's Hospital, United States of America (USA) 0.05
Faculty of Health and Medical Sciences (FHMS), University of Surrey, United Kingdom (UK) 0.05
Mayo Clinic Department of Ophthalmology, United States of America (USA) 0.05
Mayo Clinic College of Medicine and Science, United States of America (USA) 0.03
St James's University Hospital, United Kingdom (UK) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER